Patents by Inventor Kurt Andrew Brown

Kurt Andrew Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JAK1 pathway inhibitors for the treatment of vitiligo
    Patent number: 11957661
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: April 16, 2024
    Assignee: Incyte Corporation
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger
  • TREATMENT OF URTICARIA USING JAK INHIBITORS
    Publication number: 20240058343
    Abstract: The present application provides methods of treating urticaria in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound which inhibits JAK1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 4, 2023
    Publication date: February 22, 2024
    Inventors: Cornelius P. Sailer, Kurt Andrew Brown, Vijay Krishna Iyengar, James Lee, Leandro Luiz Dos Santos, Susan Harless Smith
  • JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS
    Publication number: 20220378746
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating prurigo nodularis.
    Type: Application
    Filed: May 3, 2022
    Publication date: December 1, 2022
    Inventors: Paul Smith, Kurt Andrew Brown
  • JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO
    Publication number: 20220175731
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 9, 2022
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger